BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21999648)

  • 1. Pediatric drug-resistant tuberculosis: a global perspective: a global perspective.
    Reubenson G
    Paediatr Drugs; 2011 Dec; 13(6):349-55. PubMed ID: 21999648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses.
    Pepper DJ; Rebe K; Morroni C; Wilkinson RJ; Meintjes G
    PLoS One; 2009; 4(2):e4520. PubMed ID: 19229341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
    Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-Echevarría A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
    PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing tuberculosis and HIV in sub-Sahara Africa.
    Lalloo UG; Pillay S
    Curr HIV/AIDS Rep; 2008 Aug; 5(3):132-9. PubMed ID: 18627662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-resistant tuberculosis: an insurmountable epidemic?
    Chakroborty A
    Inflammopharmacology; 2011 Jun; 19(3):131-7. PubMed ID: 21127999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study.
    Fairlie L; Beylis NC; Reubenson G; Moore DP; Madhi SA
    BMC Infect Dis; 2011 Jan; 11():28. PubMed ID: 21269475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing face of tuberculosis.
    Huebner RE; Castro KG
    Annu Rev Med; 1995; 46():47-55. PubMed ID: 7598480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensively drug-resistant tuberculosis in the United States, 1993-2007.
    Shah NS; Pratt R; Armstrong L; Robison V; Castro KG; Cegielski JP
    JAMA; 2008 Nov; 300(18):2153-60. PubMed ID: 19001626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India.
    Saldanha N; Runwal K; Ghanekar C; Gaikwad S; Sane S; Pujari S
    BMC Infect Dis; 2019 May; 19(1):391. PubMed ID: 31068153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric tuberculosis: global overview and challenges.
    Swaminathan S; Rekha B
    Clin Infect Dis; 2010 May; 50 Suppl 3():S184-94. PubMed ID: 20397947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Oct; 47(RR-20):1-58. PubMed ID: 9809743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hearing loss in children treated for multidrug-resistant tuberculosis.
    Seddon JA; Thee S; Jacobs K; Ebrahim A; Hesseling AC; Schaaf HS
    J Infect; 2013 Apr; 66(4):320-9. PubMed ID: 22960077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
    Fears R; Kaufmann S; Ter Meulen V; Zumla A;
    Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
    Umanah TA; Ncayiyana JR; Nyasulu PS
    Trans R Soc Trop Med Hyg; 2015 May; 109(5):340-8. PubMed ID: 25787727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of tuberculosis infection in children.
    Hatzenbuehler LA; Starke JR
    Expert Rev Anti Infect Ther; 2018 Sep; 16(9):695-708. PubMed ID: 30132364
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.